References

Abdala, N., Carney, J.M., Durante, A.J. etal. (2003). Estimating the prevalence of syringe-borne and sexually transmitted diseases among injection drug users in St Petersburg, Russia. International Journal of STD & AIDS 14, 697-703.

Aceijas, C., Stimson, G.V., Hickman, M. and Rhodes, T. (2004). Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 18, 2295-2303.

Ahmed, A. (1998). UN General Assembly Special Session on the World Drug Problem. UN, New York.

Alizadeh, A.H., Alavian, S.M., Jafari, K. and Yazdi, N. (2005). Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan, Iran. World Journal of Gastroenterology 11, 4085-4089.

Altice, F.L., Bruce, R.D., Walton, M.R. and Buitrago, M.I. (2005). Adherence to hepatitis B virus vaccination at syringe exchange sites. Journal of Urban Health 82, 151-161.

Backmund, M., Meyer, K., von Zielonka, M. and Eichenlaub, D. (2001). Treatment of hepatitis C infection in injection drug users. Hepatology 34, 188-193.

Ball, A.L., Rana, S. and Dehne, K.L. (1998). HIV prevention among injecting drug users: responses in developing and transitional countries. Public Health Reports 113(Suppl. 1), 170-181.

Bastos, F.I., Barcellos, C., Lowndes, C.M. and Friedman, S.R. (1999). Co-infection with malaria and HIV in injecting drug users in Brazil: a new challenge to public health? Addiction 94, 1165-1174.

Beeching, N.J. and Crowcroft, N.S. (2005). Tetanus in injecting drug users. British Medical Journal 330, 208-209.

Beld, M., Penning, M., van Putten, M. et al. (1999). Low levels of hepatitis C virus RNA in serum, plasma, and peripheral blood mononuclear cells of injecting drug users during long antibody-undetectable periods before seroconversion. Blood 94, 1183-1191.

Bellis, M.A. (2005). History of the Hypodermic Needle or Syringe. Available at: http:// inventors.about.com/library/inventors/blsyringe.htm (accessed 9 March 2006).

Bellis, M.A., Beynon, C., Millar, T. et al. (2001). Unexplained illness and deaths among injecting drug users in England: a case control study using Regional Drug Misuse Databases. Journal of Epidemiology and Community Health 55, 843-844.

Beyrer, C. (2002). Fearful symmetry: heroin trafficking and HIV spread. Bulletin on Narcotics LIV, 103.

Beyrer, C. (2005). The Next Wave: Emerging Epidemics of HIV-1 infection in Eurasia. Rio de Janeiro: International AIDS Society. Available at: http://www.kaisernetwork. org/health_cast/uploaded_files/Beyrer_slides.pdf#search=%22the%20next%20wave% 20beyrer%22.

Beyrer, C., Razak, M.H., Lisam, K. et al. (2000). Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia. AIDS 14, 75-83.

Beyrer, C., Jittiwutikarn, J., Teokul, W. et al. (2003). Drug use, increasing incarceration rates, and prison-associated HIV risks in Thailand. AIDS and Behavior 7, 153-161.

Bradshaw, C.S., Pierce, L.I., Tabrizi, S.N. et al. (2005). Screening injecting drug users for sexually transmitted infections and blood borne viruses using street outreach and self collected sampling. Sexually Transmitted Infections 81, 53-58.

Briggs, M.E., Baker, C., Hall, R. et al. (2001). Prevalence and risk factors for hepatitis C virus infection at an urban Veterans Administration medical center. Hepatology 34, 1200-1205.

Bruneau, J., Lamothe, F., Soto, J. et al. (2001). Sex-specific determinants of HIV infection among injection drug users in Montreal. Canadian Medical Association Journal 164, 767-773.

Calleja, J.M., Walker, N., Cuchi, P. et al. (2002). Status of the HIV/AIDS epidemic and methods to monitor it in the Latin America and Caribbean region. AIDS 16(Suppl. 3), S3-12.

Carey, J., Perlman, D.C., Friedmann, P. et al. (2005). Knowledge of hepatitis among active drug injectors at a syringe exchange program. Journal of Substance Abuse Treatment 29, 47-53.

Celentano, D.D., Galai, N., Sethi, A.K. et al. (2001). Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS 15, 1707-1715.

Chaisson, R.E., Bacchetti, P., Osmond, D. et al. (1989). Cocaine use and HIV infection in intravenous drug users in San Francisco. Journal of the American Medical Association 261, 561-565.

Chamla, D., Chamla, J.H., Dabin, W. et al. (2006). Transition to injection and sharing of needles/syringes: potential for HIV transmission among heroin users in Chengdu, China. Addictive Behaviors 31, 697-701.

Chau, T.T., Mai, N.T., Phu, N.H. et al. (2002). Malaria in injection drug abusers in Vietnam. Clinical Infectious Diseases 34, 1317-1322.

Choo, Q.L., Kuo, G., Weiner, A.J. et al. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359-362.

Choopanya, K., Des, J., Vanichseni, S. et al. (2003). HIV risk reduction in a cohort of injecting drug users in Bangkok, Thailand. Journal of Acquired Immune Deßciency Syndromes 33, 88-95.

Cohen, M.S., Henderson, G.E., Aiello, P. and Zheng, H. (1996). Successful eradication of sexually transmitted diseases in the People's Republic of China: implications for the 21st century. Journal oflnfectious Diseases 174(Suppl. 2), S223-229.

Cohen, P. and Lyttleton, C. (2002). Opium reduction programmes, discourses of addiction and gender in Northwest Laos. Sojourn 17, 1-23.

Correctional Association of New York (2001). Stupid and Irrational and Barbarous: New York Judges Speak Against the Rockefeller Drug Laws. Public Policy Project of the Correctional Association of NY, New York. Available at: http://www.correctional association.org/general/about/contact.html.

Cox, A.L., Netski, D.M., Mosbruger, T. et al. (2005). Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clinical Infectious Diseases 40, 951-958.

Crofts, N. (1999). The Manual for Reducing Drug Related Harm in Asia. Thailand: The Center for Harm Reduction, Macfarlane Burnet Center for Medical Research, and the Asian Harm Reduction Network.

Crofts, N., Reid, G. and Deany, P. (1998). Injecting drug use and HIV infection in Asia. The Asian Harm Reduction Network. AIDS 12(Suppl. B), S69-S78.

Davis, M., Rhodes, T. and Martin, A. (2004). Preventing hepatitis C: "common sense", "the bug" and other perspectives from the risk narratives of people who inject drugs. Social Science & Medicine 59, 1807-1818.

Deany, P. (2000). HIV and Injecting Drug Use: A New Challenge to Sustainable Human Development. Geneva: UNDP Asia-Pacific Regional Programme on HIV and Development. Available at: http://www.undp.org/hiv/publications/deany.htm.

Deany, P. and Crofts, N. (2000). Harm reduction, HIV and development. Development Bulletin 52, 45-48.

Dehovitz, J. and Uuskula, A. (2002). International Journal of Infectious Disease 6(1), 23-27.

de la Fuente, L., Bravo, M.J., Barrio, G. et al. (2003). Lessons from the history of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among Spanish drug injectors. Clinical Infectious Diseases 37(Suppl. 5), S410-415.

des Jarlais, D.C., Friedman, S.R., Choopanya, K. et al. (1992). International epidemiology of HIV and AIDS among injecting drug users. AIDS 6, 1053-1068.

des Jarlais, D.C., Hagan, H., Friedman, S.R. et al. (1995a). Maintaining low HIV sero-prevalence in populations of injecting drug users. Journal of the American Medical Association 274, 1226-1231.

des Jarlais, D.C., Friedman, S.R., Friedmann, P. ei al. (1995b). HIV/AIDS-related behavior change among injecting drug users in different national settings. AIDS 9, 611-617.

des Jarlais, D.C., Perlis, T., Arasteh, K. et al. (2005). Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001. AIDS 19(Suppl. 3), S20-25.

Dolan, K.A. and Wodak, A. (1999). HIV transmission in a prison system in an Australian State. Medical Journal of Australia 171, 14-17.

Dolan, K., Rutter, S. and Wodak, A.D. (2003). Prison-based syringe exchange programmes: a review of international research and development. Addiction 98, 153-158.

Dolan, K.A., Bijl, M. and White, B. (2004). HIV education in a Siberian prison colony for drug dependent males. International Journal for Equity in Health 3, 7.

Drobniewski, F.A., Balabanova, Y.M., Ruddy, M.C. et al. (2005). Tuberculosis, HIV sero-prevalence and intravenous drug abuse in prisoners. European Respiratory Journal 26, 298-304.

Drucker, E., Lurie, P., Wodak, A. and Alcabes, P. (1998). Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. AIDS 12 (Suppl. A), S217-230.

Duffin, J. (1999). History of Medicine: A Scandalously Short Introduction. Toronto: University of Toronto Press.

Dufour, A., Alary, M., Poulin, C. et al. (1996). Prevalence and risk behaviors for HIV infection among inmates of a provincial prison in Quebec City. AIDS 10, 1009-1015.

Field, M.G. (2004). HIV and AIDS in the former Soviet Bloc. New England Journal of Medicine 351, 117-120.

Fleming, D.T. and Wasserheit, J.N. (1999). From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sexually Transmitted Infections 75, 3-17.

Fox, R.K., Currie, S.L., Evans, J. et al. (2005). Hepatitis C virus infection among prisoners in the California state correctional system. Clinical Infectious Diseases 41, 177-186.

Fuller, C.M., Vlahov, D., Arria, A.M. et al. (2001). Factors associated with adolescent initiation of injection drug use. Public Health Reports 116(Suppl. 1), 136-145.

Garfein, R.S., Vlahov, D., Galai, N. et al. (1996). Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. American Journal ofPublic Health 86, 655-661.

Garfein, R.S., Latka, M., Hagan, H. et al. (2006). Opportunities for Reducing Sexual HIV Risk Among Young Injection Drug Users (IDUs) through Substance Abuse Treatment. Philadelphia: CIDUS-III/DUIT.

Gray, J. (1998). Harm reduction in the hills of northern Thailand. Substance Use & Misuse 33, 1075-1091.

Gray, R.H., Wawer, M.J., Brookmeyer, R. et al. (2001). Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-10-discordant couples in Rakai, Uganda. Lancet 357, 1149-1153.

Griffiths, P., Gossop, M., Powis, B. and Strang, J. (1994). Transitions in patterns of heroin administration: a study of heroin chasers and heroin injectors. Addiction 89, 301-309.

Grund, J.P. (1997). Harm Reduction and Methadone Treatment in Eastern Europe. New York: Open Society Institute.

Hagan, H., Jarlais, D.C., Friedman, S.R. et al. (1995). Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. American Journal of Public Health 85, 1531-1537.

Hagan, H., McGough, J.P., Thiede, H. et al. (1999). Syringe exchange and risk of infection with hepatitis B and C viruses. American Journal of Epidemiology 149, 203-213.

Hagan, H., Thiede, H., Weiss, N.S. et al. (2001). Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health 9l, 42-46.

Hagan, H., Thiede, H. and des Jarlais, D.C. (2004). Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion. Epidemiology 15, 543-549.

Hagan, H., Thiede, H. and des Jarlais D.C. (2005). HIV/hepatitis C virus co-infection in drug users: risk behavior and prevention. AIDS 19(Suppl. 3), S199-207.

Heather, H., Wodak, A., Nadelmann, E. and O'Hare, P. (1993). From Faith to Science: Psychoactive Drugs & Harm Reduction. London: Whurr Publishers.

Heiss, W.D and Herholz, K. (2006). Brain receptor imaging. Journal of Nuclear Medicine 47, 302-312.

Hope, VD., Judd, A., Hickman, M. et al. (2001). Prevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working? American Journal of Public Health 91, 38-42.

Horsburgh, C.R. Jr, Jarvis, J.Q., McArther, T. et al. (1990). Seroconversion to human immunodeficiency virus in prison inmates. American Journal of Public Health 80, 209-210.

Hurley, S.F., Jolley, D.J. and Kaldor, J.M. (1997). Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet 349, 1797-1800.

Hutchinson, S.J., Wadd, S., Taylor, A. et al. (2004). Sudden rise in uptake of hepatitis B vaccination among injecting drug users associated with a universal vaccine programme in prisons. Vaccine 23, 210-214.

Kane, M. (1995). Epidemiology of hepatitis B infection in North America. Vaccine 13(Suppl. 1), S16-17.

Karapetyan, A.F., Sokolovsky, Y.V., Araviyskaya, E.R. et al. (2002). Syphilis among intravenous drug-using population: epidemiological situation in St Petersburg, Russia. International Journal of STD & AIDS 13, 618-623.

Kerr, T. (2003). North America's first supervised injection site opens in Vancouver. Canadian HIV AIDS Policy and Law Review 8, 24-25.

Kerr, T., Tyndall, M., Li, K. et al. (2005). Safer injection facility use and syringe sharing in injection drug users. Lancet 366, 316-318.

Kerr, T., Stoltz, J.A., Tyndall, M. et al. (2006). Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study. British Medical Journal 332, 220-222.

Khan, A.J., Simard, E.P., Bower, W.A. et al. (2005). Ongoing transmission of hepatitis B virus infection among inmates at a state correctional facility. American Journal of Public Health 95, 1793-1799.

Kimber, J., Dolan, K., van Beek, I. et al. (2003). Drug consumption facilities: an update since 2000. Drug and Alcohol Review 22, 227-233.

Kiyosawa, K., Sodeyama, T., Tanaka, E. et al. (1991). Hepatitis C in hospital employees with needlestick injuries. Annals of Internal Medicine 115, 367-369.

Kushel, M.B., Hahn, J.A., Evans, J.L. et al. (2005). Revolving doors: imprisonment among the homeless and marginally housed population. American Journal of Public Health 95, 1747-1752.

Levinson, A., Marske, R.L. and Shein, M.K. (1955). Tetanus in heroin addicts. Journal of the American Medical Association 157, 658-660.

Linglof, T. (1995). Rapid increase of syphilis and gonorrhea in parts of the former USSR. Sexually Transmitted Diseases 22, 160-161.

Lopez-Zetina, J., Ford, W., Weber, M. et al. (2000). Predictors of syphilis seroreactivity and prevalence of HIV among street recruited injection drug users in Los Angeles County, 1994-6. Sexually Transmitted Infections 76, 462-469.

Lovell, A.M. (2002). Risking risk: the influence of types of capital and social networks on the injection practices of drug users. Social Science & Medicine 55, 803-821.

Malinowska-Sempruch, K., Hoover, J. and Alexandrova, A. (2004). Unintended consequences: drug policies fuel the HIV epidemic in Russia and Ukraine. In: K. Malinowska-Sempruch and S. Gallagher (eds), War on Drugs, HIV/AIDS, and Human Rights. New York: Idea Press.

Mann, J., Tarantola, D. and Netter, T. (1992). AIDS in the World 1992. Cambridge: Harvard University Press.

Metzger, D.S., Woody, G.E., McLellan, A.T. et al. (1993). Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. Journal of Acquired Immune Deßciency Syndromes 6, 1049-1056.

Miller, C.L., Johnston, C., Spittal, P.M. et al. (2002). Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology 36, 737-742.

Mishra, G., Sninsky, C., Roswell, R. et al. (2003). Risk factors for hepatitis C virus infection among patients receiving health care in a Department of Veterans Affairs hospital. Digestive Diseases and Sciences 48, 815-820.

Mitsui, T., Iwano, K., Masuko, K. et al. (1992). Hepatitis C virus infection in medical personnel after needlestick accident. Hepatology 16, 1109-1114.

Mocroft, A., Madge, S., Johnson, A.M. et al. (1999). A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival. Journal of Acquired Immune Deficiency Syndromes 22, 369-378.

Muga, R., Roca, J., Tor, J. et al. (1997). Syphilis in injecting drug users: clues for high-risk sexual behavior in female IDUs. International Journal of STD & AIDS 8, 225-228.

Muller, R., Stark, K., Guggenmoos-Holzmann, I. et al. (1995). Imprisonment: a risk factor for HIV infection counteracting education and prevention programmes for intravenous drug users. AIDS 9, 183-190.

National Institutes of Health Consensus Development Conference Panel Statement (1997). Management of Hepatitis C: 1997. Bethesday: NIH.

National Institutes of Health Consensus Development Conference Panel Statement (2002). Management of Hepatitis C: 2002. Bethesda: NIH.

Nelles, J., Fuhrer, A., Hirsbrunner, H. and Harding, T. (1998). Provision of syringes: the cutting edge of harm reduction in prison? British Medical Journal 317, 270-273.

Ompad, D.C., Galea, S., Wu, Y. et al. (2004). Acceptance and completion of hepatitis B vaccination among drug users in New York City. Communicable Disease and Public Health 7, 294-300.

Panda, S., Sarkar, S., Bhattacharya, S.K. et al. (1998). HIV-1 in injecting-drug users and heterosexuals. Lancet 352, 241.

Passaro, D.J., Werner, S.B., McGee, J. et al. (1998). Wound botulism associated with black tar heroin among injecting drug users. Journal of the American Medical Association 279, 859-863.

Physicians' Desk Reference (2005). 59th edn. Bridgeport: Thomson Healthcare.

Polonsky, S., Kerr, S., Harris, B. et al. (1994). HIV prevention in prisons and jails: obstacles and opportunities. Public Health Reports 109, 615-625.

Portsmouth, S., Stebbing, J., Keyi, X. et al. (2003). HIV and AIDS in the People's Republic of China: a collaborative review. International Journal ofSTD & AIDS 14, 757-761.

Razak, M.H., Jittiwutikarn, J., Suriyanon, V. et al. (2003). HIV prevalence and risks among injection and noninjection drug users in northern Thailand: need for comprehensive HIV prevention programs. Journal of Acquired Immune Deficiency Syndromes 33, 259-266.

Razzaghi, E., Nassirimanesh, B., Afshar, P. et al. (2006). HIV/AIDS harm reduction in Iran. Lancet 368, 434-435.

Reid, G. and Costigan, G. (2002). Revisiting the "Hidden Epidemic": A Situation Assessment of Drug Use in Asia in the Context of HIV/AIDS. Melbourne: The Center for Harm Reduction, The Burnet Institute.

Restrepo, A., Johnson, T.C., Widjaja, D. et al. (2005). The rate of treatment of chronic hepatitis C in patients co-infected with HIV in an urban medical centre. Journal of Viral Hepatitis 12, 86-90.

Rhodes, T., Stimson, G.V, Crofts, N. et al. (1999a). Drug injecting, rapid HIV spread, and the "risk environment": implications for assessment and response. AIDS 13(Suppl. A): S259-269.

Rhodes, T., Stimson, G.V, Fitch, C. et al. (1999b). Rapid assessment, injecting drug use, and public health. Lancet 354, 65-68.

Rhodes, T., Ball, A., Stimson, G.V. et al. (1999c). HIV infection associated with drug injecting in the newly independent states, Eastern Europe: the social and economic context of epidemics. Addiction 94, 1323-1336.

Rhodes, T., Lowndes, C., Judd, A. et al. (2002). Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia. AIDS 16, F25-31.

Rhodes, T., Davis, M. and Judd, A. (2004). Hepatitis C and its risk management among drug injectors in London: renewing harm reduction in the context of uncertainty. Addiction 99, 621-633.

Roca, B, Gomez, C.J. and Arnedo, A. (1999). Stavudine, lamivudine and indinavir in drug abusing and non-drug abusing HIV-infected patients: adherence, side effects and efficacy. Journal ofInfection 39, 141-145.

Rossi, D., Goltzman, P., Cymerman, P. et al. (2003). Human immunodeficiency virus/ acquired immunodeficiency syndrome prevention in injection drug users and their partners and children: lessons learned in Latin America - the Argentinean case. Clinical Infectious Diseases 37(Suppl. 5), S362-365.

Rothenberg, R.B., Long, D.M., Sterk, C.E. et al. (2000). The Atlanta Urban Networks Study: a blueprint for endemic transmission. AIDS 14, 2191-2200.

Roy, K., Hay, G., Andragetti, R. et al. (2002). Monitoring hepatitis C virus infection among injecting drug users in the European Union: a review of the literature. Epidemiology and Infection 129, 577-585.

Ruiz, J.D., Molitor, F. and Plagenhoef, J.A. (2002). Trends in hepatitis C and HIV infection among inmates entering prisons in California, 1994 versus 1999. AIDS 16, 2236-2238.

Satoh, Y., Hino, K., Kato, T. et al. (2004). Molecular epidemiologic analysis of hepatitis C virus infection in injecting drug users with acute hepatitis C in Japan. Journal of Gastroenterology andHepatology 19, 1305-1311.

Schutz, C.G., Rapiti, E., Vlahov, D. and Anthony, J.C. (1994). Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users. Drug and Alcohol Dependence 36, 129-138.

Seal, K.H., Ochoa, K.C., Hahn, J.A. et al. (2000). Risk of hepatitis B infection among young injection drug users in San Francisco: opportunities for intervention. West Journal of Medicine 172, 16-20.

Seal, K.H., Kral, A.H., Lorvick, J. et al. (2003). A randomized controlled trial of monetary incentives vs outreach to enhance adherence to the hepatitis B vaccine series among injection drug users. Drug and Alcohol Dependence 71, 127-131.

Senlis Council (2004). A Fourth International Convention for Drug Policy: Promoting Public Health Policies, edited by D. Spivack.

Senlis Council (2006). Drug Policy Advisory Forum. London: Senlis Council.

Simbulan, N.P., Aguilar, A.S., Flanigan, T. and Cu-Uvin, S. (2001). High-risk behaviors and the prevalence of sexually transmitted diseases among women prisoners at the women's state penitentiary in Metro Manila. Social Science & Medicine 52, 599-608.

Small, W., Kain, S., Laliberte, N. et al. (2005). Incarceration, addiction and harm reduction: inmates experience injecting drugs in prison. Substance Use & Misuse 40, 831-843.

Sorensen, J.L. and Copeland, A.L. (2000). Drug abuse treatment as an HIV prevention strategy: a review. Drug and Alcohol Dependence 59, 17-31.

Southgate, E., Weatherall, A.M., Day, C. and Dolan, K.A. (2005). What's in a virus? Folk understandings of hepatitis C infection and infectiousness among injecting drug users in Kings Cross, Sydney. International Journal for Equity in Health 4, 5.

Stern, V (2001). Problems in prisons worldwide, with a particular focus on Russia. Annals of the New York Academy of Science 953, 113-119.

Stimson, G. and Choopanya, K. (1998). Global perspectives on drug injecting. In: G. Stimson, J.D. Des and A. Ball (eds), Drug Injecting and HIV Infection: Global Dimensions and Local Responses. London: UCL Press.

Stimson, G., Des, J.D. and Ball, A. (1998). Drug Injecting and HIV Infection: Global Dimensions and Local Responses. London: UCL Press.

Stoove, M.A., Gifford, S.M. and Dore, G.J. (2005). The impact of injecting drug use status on hepatitis C-related referral and treatment. Drug and Alcohol Dependence 77, 81-86.

Stramer, S.L., Glynn, S.A., Kleinman, S.H. et al. (2004). Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. New England Journal of Medicine 351, 760-768.

Strathdee, S.A., Galai, N., Safaiean, M. et al. (2001). Sex differences in risk factors for hIV seroconversion among injection drug users: a 10-year perspective. Archives of Internal Medicine 161, 1281-1288.

Suh, D.J. and Jeong, S.H. (2006). Current status of hepatitis C virus infection in Korea. Intervirology 49, 70-75.

Sylvestre, D.L. (2002). Treating hepatitis C in methadone maintenance patients: an interim analysis. Drug and Alcohol Dependence 67, 117-123.

Taylor, A., Goldberg, D., Emslie, J. etal. (1995). Outbreak of HIV infection in a Scottish prison. British Medical Journal 310, 289-292.

Taylor, A., Goldberg, D., Hutchinson, S. et al. (2000). Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working? Journal of Infection 40, 176-183.

Thaisri, H., Lerwitworapong, J., Vongsheree, S. et al. (2003). HIV infection and risk factors among Bangkok prisoners, Thailand: a prospective cohort study. BMC Infectious Diseases 3, 25.

The World Bank (1999). Confronting AIDS, Public Health Priorities in a Global Epidemic. Oxford: Oxford University Press.

Thomas, D.L., Astemborski, J., Rai, R.M. et al. (2000). The natural history of hepatitis C virus infection: host, viral, and environmental factors. Journal of the American Medical Association 284, 450-456.

Thorpe, L.E., Ouellet, L.J., Hershow, R. et al. (2002). Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. American Journal of Epidemiology 155, 645-653.

UNAIDS (2005). Update on the Global HIV/AIDS Pandemic. Geneva: UNAIDS.

UNDCP (1998). Drug Control Brief, HIV/AIDS and Drug Abuse. Bangkok: UNDCP Regional Office for East Asia.

UNDP (1999). AIDS in South and Southwest Asia: A Development Challenge. Delhi: UNDP HIV and Development Project South and South West Asia.

UNODC (2005). World Drug Report. Vienna: United Nations Publications.

UNODC (2006). World Drug Report. Geneva: United Nations Publications.

Uusküla, A., Kalikova, A., Zilmer, K. et al. (2002). The role of injection drug use in the emergence of Human Immunodeficiency Virus infection in Estonia. International Journal of Infectious Diseases 6(1), 23-27.

Vanichseni, S., Des, J., Choopanya, K. et al. (2004). Sexual risk reduction in a cohort of injecting drug users in Bangkok, Thailand. Journal of Acquired Immune Deßciency Syndromes 37, 1170-1179.

Vlahov, D., Brewer, T.F., Castro, K.G. et al. (1991). Prevalence of antibody to HIV-1 among entrants to US correctional facilities. Journal of the American Medical Association 265, 1129-1132.

Vlahov, D., Fuller, C.M., Ompad, D.C. et al. (2004). Updating the infection risk reduction hierarchy: preventing transition into injection. Journal of Urban Health 81, 14-19.

Waley, A. (1958). The Opium War Through Chinese Eyes. Stanford: Stanford University Press.

Watson, R., Stimpson, A. and Hostick, T. (2004). Prison health care: a review of the literature. International Journal of Nursing Studies 41, 119-128.

Whitworth, J.A. and Hewitt, K.A. (2005). Effect of malaria on HIV-1 progression and transmission. Lancet 365, 196-197.

Wodak, A. and Lurie, P. (1997). A tale of two countries: attempts to control HIV among injecting drug users in Australia and the United States. Journal of Drug Issues 27, 117.

Wu, Z., Rou, K. and Cui, H. (2004). The HIV/AIDS epidemic in China: history, current strategies and future challenges. AIDS Education and Prevention 16, 7-17.

Yang, H., Li, X., Stanton, B. et al. (2005). Heterosexual transmission of HIV in China: a systematic review of behavioral studies in the past two decades. Sexually Transmitted Diseases 32, 270-280.

Zamani, S., Kihara, M., Gouya, M.M. et al. (2005). Prevalence of and factors associated with HIV-1 infection among drug users visiting treatment centers in Tehran, Iran. AIDS 19, 709-716.

Zhang, K.L. and Ma, S.J. (2002). Epidemiology of HIV in China. British Medical Journal 324, 803-804.

Zhang, C., Yang, R., Xia, X. et al. (2002). High prevalence of HIV-1 and hepatitis C virus coinfection among injection drug users in the southeastern region of Yunnan, China. Journal of Acquired Immune Deficiency Syndromes 29, 191-196.

Urbanization and the social ecology of emerging infectious diseases

Booze Basher

Booze Basher

Get All The Support And Guidance You Need To Permanently STOP The Battle With Alcohol Once And For All. This Book Is One Of The Most Valuable Resources In The World When It Comes To Transformational Tools For Battling Booze Binges And Staying Alcohol-Free.

Get My Free Ebook


Post a comment